{
  "actions": [
    {
      "acted_at": "2003-04-11", 
      "committee": "Committee on Finance", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s892-108", 
  "bill_type": "s", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "108", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2003-04-11", 
  "number": "892", 
  "official_title": "A bill to provide for substantial reductions in the price of prescription drugs for medicare beneficiaries.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Prescription Drug Fairness for Seniors Act of 2003", 
  "sponsor": {
    "district": null, 
    "name": "Johnson, Tim", 
    "state": "SD", 
    "thomas_id": "00604", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2003-04-11", 
  "subjects": [
    "Ambulatory care", 
    "Canada", 
    "Commerce", 
    "Congress", 
    "Congressional reporting requirements", 
    "Drug industry", 
    "Drugs", 
    "East Asia", 
    "Europe", 
    "Foreign trade and international finance", 
    "France", 
    "Germany", 
    "Government contractors", 
    "Government operations and politics", 
    "Health", 
    "Italy", 
    "Japan", 
    "Medicare", 
    "Pharmacies", 
    "Prescription pricing", 
    "Price discrimination", 
    "Social welfare", 
    "Terminal care", 
    "Terminally ill", 
    "United Kingdom"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced", 
    "date": "2003-04-11", 
    "text": "Prescription Drug Fairness for Seniors Act of 2003 - Requires each participating manufacturer of a covered outpatient drug to make it available for purchase by each pharmacy: (1) in an amount equal to the aggregate amount sold or distributed by the pharmacy to Medicare beneficiaries; and (2) at a price no greater than the manufacturer's average foreign price. Sets forth special provisions with respect to hospice programs."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "title": "Prescription Drug Fairness for Seniors Act of 2003", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "title": "A bill to provide for substantial reductions in the price of prescription drugs for medicare beneficiaries.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-02-02T20:32:13-05:00"
}